Healthcare provider profile · identity verified

Ruth Esther Smith, MD

Family Practice · SAINT CROIX FALLS, WI · NPI 1275887366

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	231	66
Warfarin Sodium	Warfarin Sodium	163	suppressed
Lisinopril	Lisinopril	157	41
Levothyroxine Sodium	Levothyroxine Sodium	149	34
Losartan Potassium	Losartan Potassium	120	34
Gabapentin	Gabapentin	119	30
Amlodipine Besylate	Amlodipine Besylate	117	28
Metformin Hcl	Metformin Hcl	100	31
Omeprazole	Omeprazole	93	28
Furosemide	Furosemide	88	28
Hydrochlorothiazide	Hydrochlorothiazide	87	22
Ozempic	Semaglutide	74	12
Duloxetine Hcl	Duloxetine Hcl	69	12
Metoprolol Succinate	Metoprolol Succinate	65	19
Eliquis	Apixaban	63	suppressed
Trazodone Hcl	Trazodone Hcl	59	12
Bupropion Xl	Bupropion Hcl	56	13
Carvedilol	Carvedilol	49	suppressed
Montelukast Sodium	Montelukast Sodium	49	12
Tamsulosin Hcl	Tamsulosin Hcl	44	12
Citalopram Hbr	Citalopram Hydrobromide	43	12
Alendronate Sodium	Alendronate Sodium	39	11
Metformin Hcl Er	Metformin Hcl	38	suppressed
Sertraline Hcl	Sertraline Hcl	38	suppressed
Simvastatin	Simvastatin	36	11
Spironolactone	Spironolactone	35	13
Meloxicam	Meloxicam	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	16
Famotidine	Famotidine	33	12
Topiramate	Topiramate	33	11
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	29	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Atenolol	Atenolol	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Baclofen	Baclofen	22	suppressed
Prednisone	Prednisone	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Budesonide	Budesonide	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Digoxin	Digoxin	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Cephalexin	Cephalexin	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Estradiol	Estradiol	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	12	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Finasteride	Finasteride	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error